funds as prescribed in the Notification of the Capital Market Supervisory Board concerning Rules on Delivery or Distribution of Prospectus and Offering for Sale of Investment Units. (3) in case of a
million) YoY YoY Operating Revenue 251 283 13% 871 1,194 37% Cost of sales (89) (102) 15% (289) (421) 46% Gross Profit 162 181 12% 582 773 33% Other Income 3 4 33% 9 11 22% Selling and distribution expenses
51% 405 599 48% Cost of sales (68) (111) 63% (132) (210) 59% Gross Profit 138 201 46% 273 389 42% Other Income 3 3 0% 5 5 0% Selling and distribution expenses (68) (85) 25% (134) (160) 19
Trade (DIT) The fluctuation of CPO price mentioned above had reflected the Company's business operation in the production and distribution of biodiesel from CPO industry, which is the inherent risk that
price mentioned above had reflected the Company's business operation in the production and distribution of biodiesel from CPO industry, which is the inherent risk that significantly impact on the
% 37.52 55.36 -32.23% Total Revenue 2,101.58 2,164.94 -2.93% 4,298.15 4,270.47 0.65% Cost of hospital operations (1,391.85) (1,483.35) -6.17% (2,906.95) (2,926.87) -0.68% Distribution and Administrative
(96) (114) 19% Gross Profit 168 226 35% Other income 4 3 (25%) Selling and Distribution Expenses (83) (100) 20% Administrative Expenses (46) (61) 33% Finance Cost (1) (1) 0% Profit (Loss) before Income
the Company also had revenue from inspection service for turnaround of refinery and petrochemical customer. - Cost of service, distribution costs and administrative expense were 425.44 million baht
decreased 7% in line with the decreased in revenues from sales and services. Distribution costs and administrative expenses decreased 19% due to in the second quarter of 2016, the subsidiaries have